RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.98%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.37B
AUM Growth
+$1.37B
(+28%)
Cap. Flow
+$229M
Cap. Flow
% of AUM
16.71%
Top 10 Holdings %
Top 10 Hldgs %
27.24%
Holding
130
New
25
Increased
53
Reduced
12
Closed
13
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$28.6M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$16.6M |
| 3 |
ADPT
Adeptus Health Inc.
ADPT
|
$14.2M |
| 4 |
Collegium Pharmaceutical
COLL
|
$13.5M |
| 5 |
Acadia Healthcare
ACHC
|
$11.7M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$22.5M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
$10.3M |
| 3 |
Labcorp
LH
|
$9.46M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$8.16M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
$7.98M |
Sector Composition
| 1 | Healthcare | 76.77% |
| 2 | Financials | 1.46% |
| 3 | Technology | 0.96% |
| 4 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSLT
76
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $6.51M | 0.48% |
800,000
+275,000
| +52% | +$2.24M |
|
77
Theravance Biopharma
TBPH
$692M
| $6.19M | 0.45% |
475,000
+101,000
| +27% | +$1.32M |
|
78
Assembly Biosciences
ASMB
$181M
| $6.04M | 0.44% |
313,500
-4,000
| -1% | -$77K |
|
|
NVTA
79
DELISTED
Invitae Corporation
NVTA
| $5.95M | 0.43% |
400,000
+275,000
| +220% | +$4.09M |
|
|
CORV
80
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $5.88M | 0.43% |
625,000
+60,000
| +11% | +$565K |
|
81
Tandem Diabetes Care
TNDM
$841M
| $5.8M | 0.42% |
535,000
+59,200
| +12% | +$642K |
|
82
Regeneron Pharmaceuticals
REGN
$61.1B
| $5.61M | 0.41% |
11,000
+1,000
| +10% | +$510K |
|
83
Amicus Therapeutics
FOLD
$2.39B
| $5.34M | 0.39% |
+377,500
| New | +$5.34M |
|
|
INSY
84
DELISTED
Insys Therapeutics, Inc.
INSY
| $5.28M | 0.39% |
+147,000
| New | +$5.28M |
|
|
AGN.PRA
85
DELISTED
Allergan plc.
AGN.PRA
| $5.23M | 0.38% |
+5,000
| New | +$5.23M |
|
86
MacroGenics
MGNX
$119M
| $5.22M | 0.38% |
137,500
+21,000
| +18% | +$797K |
|
|
CO
87
DELISTED
Global Cord Blood Corporation
CO
| $5.11M | 0.37% |
830,000
| – | – |
|
|
WCG
88
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.09M | 0.37% |
60,000
| – | – |
|
|
XENT
89
DELISTED
Intersect ENT, Inc
XENT
| $5.01M | 0.37% |
+175,000
| New | +$5.01M |
|
|
CERN
90
DELISTED
Cerner Corp
CERN
| $4.83M | 0.35% |
70,000
+10,000
| +17% | +$691K |
|
|
RPTP
91
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $4.82M | 0.35% |
305,000
+150,000
| +97% | +$2.37M |
|
92
Pacira BioSciences
PCRX
$1.23B
| $4.81M | 0.35% |
68,000
+17,250
| +34% | +$1.22M |
|
93
Jazz Pharmaceuticals
JAZZ
$7.96B
| $4.58M | 0.33% |
26,000
| – | – |
|
|
PETX
94
DELISTED
Aratana Therapeutics, Inc.
PETX
| $4.54M | 0.33% |
+300,000
| New | +$4.54M |
|
95
FibroGen
FGEN
$47.6M
| $4.47M | 0.33% |
190,000
+38,700
| +26% | +$909K |
|
96
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.45M | 0.32% |
32,500
| – | – |
|
|
DERM
97
DELISTED
Dermira, Inc.
DERM
| $4.39M | 0.32% |
250,001
+207,727
| +491% | +$3.65M |
|
|
ATHN
98
DELISTED
Athenahealth, Inc.
ATHN
| $4.35M | 0.32% |
+38,000
| New | +$4.35M |
|
99
Ascendis Pharma
ASND
$12.1B
| $4.24M | 0.31% |
240,000
+204,460
| +575% | +$3.61M |
|
|
ALBO
100
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $4.12M | 0.3% |
+4,000,000
| New | +$4.12M |
|